Pictured: Paul Paik
Finding
By Media Staff  |  Thursday, May 17, 2012

Memorial Sloan Kettering was one of the first centers to use this type of genetic testing for lung cancer patients and is currently one of the only centers testing for mutations in squamous cell carcinomas of the lung.

Pictured: Jonathan Coleman
Video
By Memorial Sloan Kettering  |  Monday, May 14, 2012

Dr. Coleman, who specializes in treating prostate and kidney cancers, talks about how minimally invasive surgical techniques reduce recovery time and pain, as well as improve quality of life for patients.

Pictured: William Jarnagin
Video
By Memorial Sloan Kettering  |  Monday, May 7, 2012

Dr. Jarnagin – a surgeon who treats patients with disorders of the pancreas, liver, and bile ducts – discusses the specialized expertise of surgeons at Memorial Sloan Kettering, a high-volume center.

Pictured: Valerie Rusch
Video
By Memorial Sloan Kettering  |  Thursday, May 3, 2012

Dr. Rusch, Chief of the Thoracic Service, discusses the multidisciplinary care plan that is developed for each patient by a specialized team of physicians at Memorial Sloan Kettering.

Pictured: Kimberly Van Zee
Video
By Memorial Sloan Kettering  |  Friday, April 27, 2012

Dr. Van Zee discusses the personalized care delivered by a multidisciplinary team of breast cancer experts at Memorial Sloan Kettering.

Pictured: Moritz Kircher
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, April 25, 2012

Researchers have demonstrated a technique that enables specific and accurate labeling of brain tumor tissue in mice. If proven effective in patients, the method could make complete surgical removal of brain tumors more feasible.

Pictured: Patty
Patient Story
By Memorial Sloan Kettering  |  Monday, April 23, 2012

Patty grew up playing in the sun at the beach, so when she developed a growth under her eye she knew it could be skin cancer. Experts at Memorial Sloan Kettering Basking Ridge diagnosed her with basal cell carcinoma and performed a highly specialized surgery to remove the cancer.

Pictured: Jedd Wolchok and James Allison
In the News
By Media Staff  |  Friday, April 20, 2012

In an article describing the history and promise of immunotherapy for cancer treatment, the magazine highlights the groundbreaking work of James Allison, Chair of the Sloan Kettering Institute’s Immunology Program, and medical oncologist and immunologist Jedd Wolchok.

Pictured: James Eastham
Video
By Memorial Sloan Kettering  |  Monday, April 16, 2012

James Eastham, Chief of Memorial Sloan Kettering’s Urology Service, talks about how our prostate cancer experts collaborate to maximize the likelihood of curing the cancer and limiting the side effects of treatment.

Pictured: Bruce
Patient Story
By Memorial Sloan Kettering  |  Monday, April 9, 2012

A routine blood test led to a diagnosis of bone cancer for Bruce, an otherwise healthy 43-year-old writer. Surgeons at Memorial Sloan Kettering removed his cancer and saved his leg, giving him the chance to resume his career as “the writer who walks.”

Pictured: T cells on surface on thymus
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Friday, April 6, 2012

A recent study holds promise for the development of a new type of drug to alleviate immune deficiency caused by cancer treatment, radiation injury, or certain diseases.

Pictured: American Association of Cancer Research Annual Meeting 2012
Announcement
By Media Staff  |  Tuesday, April 3, 2012

The American Association for Cancer Research (AACR), the world’s oldest and largest professional organization dedicated to advancing cancer research, held its 2012 annual meeting in Chicago.

Pictured: Sergio Giralt
Q&A
By Memorial Sloan Kettering  |  Monday, March 26, 2012

Adult Bone Marrow Transplantation Service Chief Sergio Giralt explains recent advances that are enabling more patients to survive the most difficult period after receiving a transplant.

Pictured: Elizabeth Morris
In the O.R.
By Esther Napolitano, BS and Allyson Collins, MS
Friday, March 16, 2012

Memorial Sloan Kettering is the first and only hospital in New York, New Jersey, and Connecticut to offer a new, more patient-friendly approach for doctors to precisely pinpoint and remove small breast cancers.

Pictured: Ross Levine
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Thursday, March 15, 2012

Researchers have identified a set of genetic abnormalities that can enhance prognostic accuracy and aid treatment selection for people with acute myelogenous leukemia (AML).

Center News

Stay Informed

Get the latest information about cancer care and research every month.